Further analysis has revealed that miR-132 exerts tumor-suppressing effects through inactivation of the Akt-signaling pathway, specifically by reducing Akt phosphorylation and the concentration of cyclin D1; therefore, decreased expression of miR-132 may contribute to the development of HBV-related HCC [217]. Here, AKT1 is linked to neoplasm.